Aster Capital Management (Difc) LTD Cogent Biosciences, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $540 Billion
- Q1 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 2,061 shares of COGT stock, worth $11,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,061
Previous 595
246.39%
Holding current value
$11,417
Previous $4.64 Million
234.39%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding COGT
# of Institutions
196Shares Held
116MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$50.4 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$49.7 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$49.3 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$40.4 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$38.6 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $364M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...